Navigatie

1.  Prager N, Bickett K, French N, Marcovici G. A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia.
J Altern Complement Med 2002;8:143-152. 

2.  Papaioannou M, Schleich S, Prade I, Degen S, Roell D, Schubert U, Tanner T, Claessens F, Matusch R, Baniahmad A. The natural compound atraric acid (pygeum africanum) is an antagonist of the human androgen receptor inhibiting cellular invasiveness and prostate cancer cell growth. J Cell Mol Med 2008 (Jul) (Epub ahead of print). 

3.  Abe M, Ito Y, Oyunzul L, Oki-Fujino T, Yamada S. Pharmacologically relevant receptor binding characteristics and 5 alpha-reductase inhibitory activity of free Fatty acids contained in saw palmetto extract. Biol Pharm Bull 2009; 32: 646-650.

4.  McElwee KJ, Niiyama S, Freyschmidt-Paul P, Wenzel E, Kissling S, Sundberg JP, Hoffmann R. Dietary soy oil content and soy-derived phytoestrogen genistein increase resistance to alopecia areata onset in C3H/HeJ mice. Exp Dermatol 2003;12:30-36

5. Lengg N. Heidecker B, Seifert B, Truëb RM. Dietary supplement increases anagen hair rate in women with telogen effluvium: result of a double-blind, placebo-controlled trial. Therapie 2007;4: 59-65.

6.  Harada N, Okajima K, Arai M, Kurihara H, Nakagata N. Administration of capsaicin and isoflavone promotes hair growth by increasing insulin-like growth factor-I production in mice and in humans with alopecia. Growth Horm IGF Res 2007;17:408-415.

7.  Hertel H, Gollnick H, Matthies C, Baumann I, Orfanos CE. Low dosage retinol and L-cystine combination improve alopecia of the diffuse type following long-term oral administration. Hautarzt 1989;40:490-495.

8.  Budde J, Tronnier H, Rahlfs VW, Frei-Kleiner S. Systemic therapy of diffuse effluvium and hair structure damage. Hautarzt 1993;44:380-384.

9.  Trüeb RM. Idiopathic chronic telogen effluvium in women. Hautarzt 2000;51:899-905.

10. Wolloba F, Jablonska S. Zinc in the treatment of alopecia areata. In: Kobori Y, Montagna W, eds. Biology and diseases of the hair. Tokyo: University park Press, 1976: 305.

11. Mock DM. Skin manifestations in biotin deficiency. Semin Dermatol 1991; 10: 296-302.

12. Georgala S, Schulpis K, Papakonstantinou ED, Kalogirou S, Michas T. Possible involvement of partial biotinidase deficiency in alopecia areata. J Eur Acad Dermatol Venereol 1996; 7: 135-138.

13. Camacho F. M, M.J. Garcia-Hernandez. Zinc aspartate, biotin and clobetasol propionate in the treatment of alopecia areata in childhood. Pediatric Dermatology 1999; 16: 336-338.

14. Rushton D. H. Nutritional factors and hair loss. Clinical and Experimental Dermatology 2002; 27: 396-404.

15. Mukherjee N, Burkhart C. N., Morrell D. S. Treatment of alopecia areata in children. Pediatr Ann. 2009;38(7):388-95.

16. Fischer TW, Trüeb RM, Hänggi G, Innocenti M, Elsner P. Topical melatonin for treatment of androgenetic alopecia. Int J Trichology 2012; 4: 236-245

Voor lezing van de samenvattingen van deze publicaties ga naar www.pubmed.com en zoek op auteursnamen

© 2008 - 2017 Dermatheek.nl | sitemap | rss | webwinkel beginnen - powered by Mijnwebwinkel